Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy

Abstract

Using an approach of widespread ACEI/ARB treatment and targeted IS, 76% of patients can expect to have achieved at least one PR by 5 years. Achievement of remission is the factor most strongly associated with reduced risk of RRT and death. Treatment with IS is associated with significant treatment complications.